Sign In
Buy IART
$16.10
+0.430 (+2.74%)
At Close: Jun 03, 2026
Integra LifeSciences Announces CEO Succession Plan
08:30am, Thursday, 24'th Jun 2021
Peter Arduini to serve as President and CEO through the end of 2021 Candidate search launched to identify successor Peter Arduini to serve as President and CEO through the end of 2021 Candidate search
Integra (IART) Tissue Technologies Rebounds Amid Supply Woe
10:31am, Tuesday, 01'st Jun 2021
Integra's (IART) CSS segment too reflects a gradual recovery in procedure-based market as well as an improvement in hospital capital spending during the first quarter.
Integra LifeSciences Hosts Virtual Investor Day
06:00am, Thursday, 20'th May 2021
PRINCETON, N.J., May 20, 2021 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will host an Investor Day meeting from 8:30 a.m
Integra LifeSciences to Host Virtual Investor Day on May 20, 2021
08:30am, Friday, 07'th May 2021
PRINCETON, N.J., May 07, 2021 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will host an Investor Day meeting from 8:30 a.m
Integra LifeSciences Holdings Corporation (IART) CEO Peter Arduini on Q1 2021 Results - Earnings Call Transcript
11:09pm, Wednesday, 28'th Apr 2021
Integra LifeSciences Holdings Corporation (IART) CEO Peter Arduini on Q1 2021 Results - Earnings Call Transcript
Integra LifeSciences (IART) Q1 Earnings and Revenues Top Estimates
08:32am, Wednesday, 28'th Apr 2021
Integra (IART) delivered earnings and revenue surprises of 23.21% and 2.92%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Integra Lifesciences: Q1 Earnings Insights
07:11am, Wednesday, 28'th Apr 2021
Shares of Integra Lifesciences (NASDAQ:IART) rose 1.5% in pre-market trading after the company reported Q1 results. Quarterly Results Earnings per share increased 43.75% over the past year to $0.69, w
Integra LifeSciences Reports First Quarter 2021 Financial Results
06:00am, Wednesday, 28'th Apr 2021
PRINCETON, N.J., April 28, 2021 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, today reported financial results for the firs
Medical Product Stocks' Earnings on Apr 28: BSX, ALGN & More
09:47am, Tuesday, 27'th Apr 2021
The sector's Q1 results are likely to reflect solid earnings and revenue growth on strong base business recovery.
Integra (IART) to Report Q1 Earnings: What's in the Offing?
12:01pm, Thursday, 22'nd Apr 2021
The acquisition of ACell, and faster recovery growth rate in Japan and China are likely to have helped recover Integra's first-quarter 2021 performance.
Orthopedic Space Gains Momentum in 2021: 5 Stocks in Focus
09:46am, Thursday, 22'nd Apr 2021
Here are five orthopedic device stocks, Integra (IART), Conformis (CFMS), SeaSpine (SPNE), Zimmer Biomet (ZBH), Orthofix (OFIX), which are expected to continue their run over the next few months.
Integra (IART) Hits New 52-Week High: What's Driving It?
09:01am, Tuesday, 20'th Apr 2021
Integra (IART) is optimistic about maintaining its strength in its international business, along with its portfolio optimization strategy.
PRINCETON, N.J., April 19, 2021 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART), a leading global medical technology company and manufacturer of SurgiMend Collagen Matrix,
Integra LifeSciences to Host First Quarter 2021 Financial Results Conference Call on April 28, 2021
04:00pm, Thursday, 08'th Apr 2021
PRINCETON, N.J., April 08, 2021 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will release first quarter 2021 financial res
Integra LifeSciences Appoints Shaundra Clay as Director
04:15pm, Thursday, 01'st Apr 2021
PRINCETON, N.J., April 01, 2021 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART), a leading global medical technology company, today announced the appointment of Shaundra C
